Pfizer's quarterly performance has been strong, which is helping CEO Albert Bourla in his efforts to improve the company's image and operations.

The company's results show an increase in demand for its products, especially after the challenges faced during the pandemic. This positive financial performance has boosted investor confidence, as Pfizer continues to navigate a competitive market and focus on innovation and growth.

This quarter's success is seen as a crucial moment for Bourla as he works towards a more robust future for the company in a changing market.